Skip to main content
PMC home page
Annals of Surgery logoLink to Annals of Surgery
. 1988 Aug;208(2):190–195. doi: 10.1097/00000658-198808000-00010

Failure of hepatic adenomas (HCA) to regress after discontinuance of oral contraceptives. An association with focal nodular hyperplasia (FNH) and uterine leiomyoma.

W H Marks 1, N Thompson 1, H Appleman 1
PMCID: PMC1493612  PMID: 2840865

Abstract

Oral contraceptives have been implicated in the development of hepatic cellular adenomas (HCA) and associated in at least one report with focal nodular hyperplasia (FNH). Recurrence of lesions or progression while the patient is no longer receiving exogenous steroids is less well documented. Three cases are reported in which progression or recurrence of HCA after the discontinuance of steroids was documented. In addition, FNH and uterine leiomyomas with HCA were observed in all three cases. The mechanism of tumor formation secondary to the use of oral contraceptives remains undetermined. In two cases, liver tissues were tested for estrogen receptors; both were found to be negative. Although technique as well as the observed progression of these lesions or development of new lesions after the discontinuance of steroids may account for this negative finding, it suggests that induction of this process may be caused by means other than direct cellular stimulation by the exogenous hormones. Finally, these three cases call attention to a potential subgroup of patients having oral contraceptive-associated HCA who may have progression of their liver tumors when no longer receiving steroids and who require an aggressive treatment program and noninvasive follow-up examinations.

Full text

PDF
190

Images in this article

191Fig. 1.
on p.191
192Fig. 2A.
on p.192
192Fig. 2B.
on p.192
193Fig. 3.
on p.193
193Figs. 4A and B.
on p.193
194Fig. 5.
on p.194
194Fig. 6.
on p.194

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ameriks J. A., Thompson N. W., Frey C. F., Appelman H. D., Walter J. F. Hepatic cell adenomas, spontaneous liver rupture, and oral contraceptives. Arch Surg. 1975 May;110(5):548–557. doi: 10.1001/archsurg.1975.01360110094017. [DOI] [PubMed] [Google Scholar]
  2. Baum J. K., Bookstein J. J., Holtz F., Klein E. W. Possible association between benign hepatomas and oral contraceptives. Lancet. 1973 Oct 27;2(7835):926–929. doi: 10.1016/s0140-6736(73)92594-4. [DOI] [PubMed] [Google Scholar]
  3. Christopherson W. M., Mays E. T. Liver tumors and contraceptive steroids: experience with the first one hundred registry patients. J Natl Cancer Inst. 1977 Feb;58(2):167–171. doi: 10.1093/jnci/58.2.167. [DOI] [PubMed] [Google Scholar]
  4. Coire C. I., Qizilbash A. H., Castelli M. F. Hepatic adenomata in type Ia glycogen storage disease. Arch Pathol Lab Med. 1987 Feb;111(2):166–169. [PubMed] [Google Scholar]
  5. Edmondson H. A., Henderson B., Benton B. Liver-cell adenomas associated with use of oral contraceptives. N Engl J Med. 1976 Feb 26;294(9):470–472. doi: 10.1056/NEJM197602262940904. [DOI] [PubMed] [Google Scholar]
  6. Fink A. S., Appelman H. D., Thompson N. W. Hemorrhage into a hepatic adenoma and type Ia glycogen storage disease: a case report and review of the literature. Surgery. 1985 Jan;97(1):117–124. [PubMed] [Google Scholar]
  7. Fischer G., Hartmann H., Droese M., Schauer A., Bock K. W. Histochemical and immunohistochemical detection of putative preneoplastic liver foci in women after long-term use of oral contraceptives. Virchows Arch B Cell Pathol Incl Mol Pathol. 1986;50(4):321–337. doi: 10.1007/BF02889911. [DOI] [PubMed] [Google Scholar]
  8. Gonzalez F., Marks C. Hepatic tumors and oral contraceptives: surgical management. J Surg Oncol. 1985 Jul;29(3):193–197. doi: 10.1002/jso.2930290313. [DOI] [PubMed] [Google Scholar]
  9. Kerlin P., Davis G. L., McGill D. B., Weiland L. H., Adson M. A., Sheedy P. F., 2nd Hepatic adenoma and focal nodular hyperplasia: clinical, pathologic, and radiologic features. Gastroenterology. 1983 May;84(5 Pt 1):994–1002. [PubMed] [Google Scholar]
  10. Klatskin G. Hepatic tumors: possible relationship to use of oral contraceptives. Gastroenterology. 1977 Aug;73(2):386–394. [PubMed] [Google Scholar]
  11. Mariani A. F., Livingstone A. S., Pereiras R. V., Jr, van Zuiden P. E., Schiff E. R. Progressive enlargement of an hepatic cell adenoma. Gastroenterology. 1979 Dec;77(6):1319–1325. [PubMed] [Google Scholar]
  12. McAvoy J. M., Tompkins R. K., Longmire W. P. Benign hepatic tumors and their association with oral contraceptives. Arch Surg. 1976 Jul;111(7):761–767. doi: 10.1001/archsurg.1976.01360250037007. [DOI] [PubMed] [Google Scholar]
  13. Nissen E. D., Kent D. R., Nissen S. E. Role of oral contraceptive agents in the pathogenesis of liver tumors. J Toxicol Environ Health. 1979 Mar-May;5(2-3):231–254. doi: 10.1080/15287397909529747. [DOI] [PubMed] [Google Scholar]
  14. Porter L. E., Elm M. S., Van Thiel D. H., Eagon P. K. Hepatic estrogen receptor in human liver disease. Gastroenterology. 1987 Mar;92(3):735–745. doi: 10.1016/0016-5085(87)90026-6. [DOI] [PubMed] [Google Scholar]
  15. Scott L. D., Katz A. R., Duke J. H., Cowan D. F., Maklad N. F. Oral contraceptives, pregnancy, and focal nodular hyperplasia of the liver. JAMA. 1984 Mar 16;251(11):1461–1463. [PubMed] [Google Scholar]
  16. Scott L. D., Katz A. R., Duke J. H., Cowan D. F., Maklad N. F. Oral contraceptives, pregnancy, and focal nodular hyperplasia of the liver. JAMA. 1984 Mar 16;251(11):1461–1463. [PubMed] [Google Scholar]
  17. Sherlock S. Hepatic reactions to drugs. Gut. 1979 Jul;20(7):634–648. doi: 10.1136/gut.20.7.634. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Stauffer J. Q., Hill R. B. Editorial: Systemic contraceptives and liver tumors. Ann Intern Med. 1976 Jul;85(1):122–123. doi: 10.7326/0003-4819-85-1-122. [DOI] [PubMed] [Google Scholar]
  19. Terblanche J., Goldin A. R., Campbell J. A., Kirsch R. E., Louw J. H. Liver tumours and the contraceptive pill: Controversies in aetiology, diagnosis and management. S Afr Med J. 1979 Nov 24;56(22):932–940. [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES